HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Yoshiki Sawa Hikaru Matsuda Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bai, H.-z. Articles by Matsuda, H. Search for Related Content PubMed PubMed Citation Articles by Bai, H.-z. Articles by Matsuda, H.

Ann Thorac Surg 1998;66:814-819
© 1998 The Society of Thoracic Surgeons

---

Original articles: Cardiovascular

Gene transfer to vein graft wall by HVJ–liposome method: time course and localization of gene expression

^a First Department of Surgery, Osaka University Medical School, Osaka, Japan
^b Department of Geriatric Medicine, Osaka University Medical School, Osaka, Japan
^c Institute for Molecular and Cellular Biology, Osaka University, Osaka, Japan

Accepted for publication April 30, 1998.

Address reprint requests to Dr Matsuda, First Department of Surgery, Osaka University Medical School, Yamada-Oka 2-2, Suita, Osaka 565, Japan

Background. A novel gene transfer method using liposomes with a viral envelope of hemagglutinating virus of Japan (HVJ) has been reported to be very effective for gene transfection into somatic cells and might be applicable to improve the patency of vein grafts. The present study examined the time course and localization of gene expression to assess the feasibility of ex vivo gene transfer into the vein graft by the HVJ–liposome method.

Methods. The HVJ–liposome complex containing either ß-galactosidase plasmid DNA (deoxyribonucleic acid) or no genes (controls) (experiment 1) or fluorescein isothiocyanate–labeled oligonucleotides either with or without HVJ-liposomes (experiment 2) was infused into rabbit vein grafts and allowed to incubate before autologous transplantation to carotid arteries.

Results. In experiment 1, all grafts incubated with ß-galactosidase plasmid with HVJ-liposomes showed the blue staining of X-gal 7 days after operation, whereas the controls did not. The blue granules were present in the medial and adventitial tissue and were still present after 14 days. In experiment 2, many fluorescein isothiocyanate–labeled nuclei were observed in the graft wall 2 and 4 days after operation and remained present mainly in the media of HVJ-liposome–treated grafts after 7 and 14 days, when no fluorescein isothiocyanate activity was observed without HVJ–liposome treatment.

Conclusions. These results demonstrated the feasibility of ex vivo transfection to the medial and adventitial tissue of the vein graft by the HVJ–liposome method and suggest the possibility of its clinical application to prevent vein graft failure.

This article has been cited by other articles:

				V. P. Torchilin, T. S. Levchenko, R. Rammohan, N. Volodina, B. Papahadjopoulos-Sternberg, and G. G. M. D'Souza Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes PNAS, February 18, 2003; 100(4): 1972 - 1977. [Abstract] [Full Text] [PDF]

				C. K. Chiu-Pinheiro, T. O'Brien, Z. S. Katusic, L. F. Bonilla, C. E. Hamner, and H. V. Schaff Gene transfer to coronary artery bypass conduits Ann. Thorac. Surg., October 1, 2002; 74(4): 1161 - 1166. [Abstract] [Full Text] [PDF]